These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 30667539)

  • 1. Integrating clinical, molecular, proteomic and histopathological data within the tissue context: tissunomics.
    Ramón Y Cajal S; Hümmer S; Peg V; Guiu XM; De Torres I; Castellvi J; Martinez-Saez E; Hernandez-Losa J
    Histopathology; 2019 Jul; 75(1):4-19. PubMed ID: 30667539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic aberrations in spitzoid melanocytic tumours and their implications for diagnosis, prognosis and therapy.
    Wiesner T; Kutzner H; Cerroni L; Mihm MC; Busam KJ; Murali R
    Pathology; 2016 Feb; 48(2):113-31. PubMed ID: 27020384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances and opportunities in proteomic analyses of tumour heterogeneity.
    Bateman NW; Conrads TP
    J Pathol; 2018 Apr; 244(5):628-637. PubMed ID: 29344964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spatial biology of cancer evolution.
    Seferbekova Z; Lomakin A; Yates LR; Gerstung M
    Nat Rev Genet; 2023 May; 24(5):295-313. PubMed ID: 36494509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conjunctival malignant melanoma in Denmark: epidemiology, treatment and prognosis with special emphasis on tumorigenesis and genetic profile.
    Larsen AC
    Acta Ophthalmol; 2016 May; 94 Thesis 1():1-27. PubMed ID: 27192168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Image-based computational quantification and visualization of genetic alterations and tumour heterogeneity.
    Zhong Q; Rüschoff JH; Guo T; Gabrani M; Schüffler PJ; Rechsteiner M; Liu Y; Fuchs TJ; Rupp NJ; Fankhauser C; Buhmann JM; Perner S; Poyet C; Blattner M; Soldini D; Moch H; Rubin MA; Noske A; Rüschoff J; Haffner MC; Jochum W; Wild PJ
    Sci Rep; 2016 Apr; 6():24146. PubMed ID: 27052161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Control of cancer formation by intrinsic genetic noise and microenvironmental cues.
    Brock A; Krause S; Ingber DE
    Nat Rev Cancer; 2015 Aug; 15(8):499-509. PubMed ID: 26156637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intra-tumour heterogeneity - going beyond genetics.
    Caiado F; Silva-Santos B; Norell H
    FEBS J; 2016 Jun; 283(12):2245-58. PubMed ID: 26945550
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Chung WJ; Daemen A; Cheng JH; Long JE; Cooper JE; Wang BE; Tran C; Singh M; Gnad F; Modrusan Z; Foreman O; Junttila MR
    Proc Natl Acad Sci U S A; 2017 Dec; 114(51):E10947-E10955. PubMed ID: 29203670
    [No Abstract]   [Full Text] [Related]  

  • 10. Tissue-specific tumorigenesis: context matters.
    Schneider G; Schmidt-Supprian M; Rad R; Saur D
    Nat Rev Cancer; 2017 Apr; 17(4):239-253. PubMed ID: 28256574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cooperation of Genomic, Transcriptomics and Proteomic Methods in the Detection of Mutated Proteins.
    Zavadil Kokáš F; Faktor J; Vojtěšek B
    Klin Onkol; 2019; 32(Supplementum 3):78-84. PubMed ID: 31627710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative analysis of primary tumour and matched metastases in colorectal cancer patients: evaluation of concordance between genomic and transcriptional profiles.
    Vignot S; Lefebvre C; Frampton GM; Meurice G; Yelensky R; Palmer G; Capron F; Lazar V; Hannoun L; Miller VA; André F; Stephens PJ; Soria JC; Spano JP
    Eur J Cancer; 2015 May; 51(7):791-9. PubMed ID: 25797355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Searching for cancer vulnerabilities amid genetic chaos.
    Speicher MR
    Genome Biol; 2017 Aug; 18(1):147. PubMed ID: 28768521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defining a metabolic landscape of tumours: genome meets metabolism.
    Seth Nanda C; Venkateswaran SV; Patani N; Yuneva M
    Br J Cancer; 2020 Jan; 122(2):136-149. PubMed ID: 31819196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic origins of spatial organization in the tumor microenvironment.
    Carmona-Fontaine C; Deforet M; Akkari L; Thompson CB; Joyce JA; Xavier JB
    Proc Natl Acad Sci U S A; 2017 Mar; 114(11):2934-2939. PubMed ID: 28246332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor and the microenvironment: a chance to reframe the paradigm of carcinogenesis?
    Bizzarri M; Cucina A
    Biomed Res Int; 2014; 2014():934038. PubMed ID: 25013812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systems heterogeneity: An integrative way to understand cancer heterogeneity.
    Wang DC; Wang X
    Semin Cell Dev Biol; 2017 Apr; 64():1-4. PubMed ID: 27552921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A 2015 update on predictive molecular pathology and its role in targeted cancer therapy: a review focussing on clinical relevance.
    Dietel M; Jöhrens K; Laffert MV; Hummel M; Bläker H; Pfitzner BM; Lehmann A; Denkert C; Darb-Esfahani S; Lenze D; Heppner FL; Koch A; Sers C; Klauschen F; Anagnostopoulos I
    Cancer Gene Ther; 2015 Sep; 22(9):417-30. PubMed ID: 26358176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nuclear factor one transcription factors as epigenetic regulators in cancer.
    Fane M; Harris L; Smith AG; Piper M
    Int J Cancer; 2017 Jun; 140(12):2634-2641. PubMed ID: 28076901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumours associated with BAP1 mutations.
    Murali R; Wiesner T; Scolyer RA
    Pathology; 2013 Feb; 45(2):116-26. PubMed ID: 23277170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.